Role OverviewAs a biotech investment analyst, you will create and critique rubrics that analyze commercial drugs and drug-development programs, assess company and asset value, and evaluate investment-style theses. You will work independently and asynchronously to meet deadlines and improve AI model performance.
What You Will Do
Your main responsibilities will include creating and critiquing rubrics, providing overall company and asset assessment, judging the quality of investment-style theses, and applying your assessment across a set of companies.
Why It Might Be a Fit
This role requires a US-based biotech/healthcare investment analyst with a specialist-fund background, familiarity with biotech/pharma development programs, and the ability to assess a drug asset and the company behind it end-to-end.
Requirements
- US-based biotech/healthcare investment analyst with a specialist-fund background
- Familiarity with biotech/pharma development programs
- Able to assess a drug asset and the company behind it end-to-end
- 5+ years evaluating biotech/pharma companies or assets
]]>